KATHERINE STUART: Open Payments
NPI 1679060198 · DESTIN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,242 in 51 payments from 27 companies in 2025. Trend: 2023 $1,892 · 2024 $1,930 · 2025 $1,242
Food & beverage: $1,242
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 6 | $184 |
| Lundbeck LLC | 4 | $109 |
| ACADIA Pharmaceuticals Inc | 3 | $106 |
| ABBVIE INC. | 4 | $103 |
| Eisai Inc. | 5 | $86 |
| PFIZER INC. | 4 | $82 |
| Novartis Pharmaceuticals Corporation | 3 | $71 |
| Amneal Pharmaceuticals LLC | 2 | $40 |
| MDD US Operations, LLC | 1 | $37 |
| ARGENX US, INC. | 1 | $34 |
Products named: NUPLAZID, VYEPTI, Leqembi, NURTEC ODT, Zilbrysq, KESIMPTA, CREXONT, UBRELVY.
Industry payments across FL — which companies pay providers there.
